415 related articles for article (PubMed ID: 23343901)
1. Multiple serotonergic paths to antidepressant efficacy.
Lutz PE
J Neurophysiol; 2013 May; 109(9):2245-9. PubMed ID: 23343901
[TBL] [Abstract][Full Text] [Related]
2. [The influence of genetic variations on the effect of selective serotonin reuptake inhibitors].
Bukh JO; Bock C; Mors NP; Kessing LV
Ugeskr Laeger; 2007 Apr; 169(16):1439-41. PubMed ID: 17484840
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus.
Asaoka N; Nagayasu K; Nishitani N; Yamashiro M; Shirakawa H; Nakagawa T; Kaneko S
Neuropharmacology; 2015 Aug; 95():261-8. PubMed ID: 25863120
[TBL] [Abstract][Full Text] [Related]
4. [Antidepressive pharmacotherapy: changing paradigms].
Bánki MC
Neuropsychopharmacol Hung; 2004 Mar; 6(1):1-3. PubMed ID: 15125307
[No Abstract] [Full Text] [Related]
5. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
Blier P; Bergeron R; de Montigny C
Neuropsychopharmacology; 1997 May; 16(5):333-8. PubMed ID: 9109104
[TBL] [Abstract][Full Text] [Related]
6. Norepinephrine involvement in antidepressant action.
Frazer A
J Clin Psychiatry; 2000; 61 Suppl 10():25-30. PubMed ID: 10910014
[TBL] [Abstract][Full Text] [Related]
7. Venlafaxine: a 2003 update.
Gutierrez MA; Stimmel GL; Aiso JY
Clin Ther; 2003 Aug; 25(8):2138-54. PubMed ID: 14512125
[TBL] [Abstract][Full Text] [Related]
8. Newer antidepressants. Beyond selective serotonin reuptake inhibitor antidepressants.
McConville BJ; Chaney RO; Browne KL; Friedman L; Cottingham E; Nelson D
Pediatr Clin North Am; 1998 Oct; 45(5):1157-71. PubMed ID: 9884680
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
Sánchez C; Hyttel J
Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
[TBL] [Abstract][Full Text] [Related]
10. A novel 5HT3 receptor-IGF1 mechanism distinct from SSRI-induced antidepressant effects.
Kondo M; Koyama Y; Nakamura Y; Shimada S
Mol Psychiatry; 2018 Apr; 23(4):833-842. PubMed ID: 28439104
[TBL] [Abstract][Full Text] [Related]
11. Paxil (paroxetine) lifts depression, lowers associated anxiety symptoms.
Adv Nurse Pract; 1997 Oct; 5(10):71. PubMed ID: 9459990
[No Abstract] [Full Text] [Related]
12. [Is it feasible to develop a 5-HT basis for the treatment of depression?].
Hamon M
Encephale; 1995 Dec; 21 Spec No 4():27-32. PubMed ID: 8808343
[No Abstract] [Full Text] [Related]
13. Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression.
Trivedi MH; Hollander E; Nutt D; Blier P
J Clin Psychiatry; 2008 Feb; 69(2):246-58. PubMed ID: 18363453
[TBL] [Abstract][Full Text] [Related]
14. Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response.
Andrews PW; Bharwani A; Lee KR; Fox M; Thomson JA
Neurosci Biobehav Rev; 2015 Apr; 51():164-88. PubMed ID: 25625874
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology Update: The Selective Serotonin Reuptake Inhibitors.
Lorman WJ
J Addict Nurs; 2018; 29(4):260-261. PubMed ID: 30507822
[No Abstract] [Full Text] [Related]
16. [Current pharmacologic aspects of antidepressive agents].
Allain H
Encephale; 1994 Dec; 20 Spec No 4():710. PubMed ID: 7895642
[No Abstract] [Full Text] [Related]
17. Neurochemical alterations of serotonergic neuronal systems in depression.
Risch SC; Nemeroff CB
J Clin Psychiatry; 1992 Oct; 53 Suppl():3-7. PubMed ID: 1331029
[TBL] [Abstract][Full Text] [Related]
18. [Serotonin neurotrasmission and treatment options for depression].
Sivolap YP
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):174-177. PubMed ID: 29265105
[TBL] [Abstract][Full Text] [Related]
19. New antidepressants: more options for tailoring treatment.
Muzina DJ; Malone DA
Cleve Clin J Med; 1996; 63(7):406-12; quiz 420. PubMed ID: 8961619
[TBL] [Abstract][Full Text] [Related]
20. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
